Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found promise in permanently eliminating the virus, thanks to a drug already approved ...

New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...

A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published research from the pivotal phase-three study "Purpose 2". The option to ...

Data from researchers working with children who acquired HIV from their mothers through pregnancy, childbirth, or breastfeeding has shown that antiretroviral (ARV) drugs administered early in their ...

At this week's meeting, Gupta said that an additional year of more extensive testing had found no functional HIV in the man's blood, lymph nodes, semen, gut tissue or cerebrospinal fluid. "After 2.5 ...

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV.

Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune system and can be life-threatening if left untreated. Although there is ...